Concepedia

Publication | Closed Access

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

1.6K

Citations

35

References

2010

Year

References

YearCitations

Page 1